ArticleFrontiers in health services2025
Complication development trajectories for patients with type 2 diabetes mellitus: evidence from a five-million retrospective cohort study.
Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Trial
- Medication adherence and associated factors in patients with chronic hepatitis B in Zhejiang Province, Eastern China.BMC public health · 2026Article
- Data Resource Profile: Cheeloo Lifespan Electronic-health reseArch Data-library (Cheeloo LEAD).International journal of epidemiology · 2026Article
- Wise Prescriptions: Prevalence and Predictors of Polypharmacy in Patients with Type 2 Diabetes Mellitus in Primary Care: A Retrospective Cross-Sectional Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a growing health burden in China. High complication rates contribute to increased morbidity, mortality, and costs. However, evidence is limited regarding how these complications develop and cluster over time in real-world settings, which this study examined. Methods: This retrospective cohort study used big data from the Cheeloo Lifespan Electronic Health Research Data Library, comprising data from over 5 million individuals in Shandong Province, China, to investigate the trajectories, onset timing and key risk factors of T2DM-related complications. Results: The prevalence of T2DM-related complications increased from 30.4% in 2013 to 53.1% in 2023. The median time from diagnosis to the first complication was 7.5 years. Ophthalmic, neurological, and circulatory complications were among the most common and showed the largest relative increases in prevalence over the study period. Complication profiles exacerbated over time: most patients developed multiple complications by Year 9. Frequent follow-up visits (≥4 times/year) and using primary health care (PHC) services were significantly associated with a reduced risk of complications, whereas being unmarried, being overweight, being obese, alcohol use, and poor medication adherence were significantly associated with a higher risk. Conclusion: Patients with T2DM in China face a substantial and growing burden of complications, with most developing multiple complications within ten years of diagnosis. Follow-up visits, the use of PHC services, and regular medication adherence are potential protective factors to prevent or delay the development of complication. These findings highlight the importance of integrated, community-based, and personalized management strategies to improve outcomes in T2DM populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.